Publication | Open Access
Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice.
426
Citations
26
References
1989
Year
Acute Lung InjuryInflammatory Lung DiseaseLung InflammationInnate Immune SystemImmunologyPulmonary Alveolar ProteinosisImmunologic MechanismInnate ImmunityImmunotherapySingle Intracheal DoseLung TissueInflammationImmunopathologyMacrophage BiologyAllergyAlveolar Macrophage EliminationPulmonary FibrosisAutoimmunityAm EliminationPharmacologyPulmonary DiseasePhagocyteInfectious Respiratory DiseasePulmonary Immune ResponseMedicine
A single intracheal dose of liposome-encapsuled dichloro-methylene-diphosphonate resulted in the elimination of alveolar macrophages (AM) from the lung, creating a model to study the in vivo role of AM in the pulmonary immune response. Using intratracheally administered trinitrophenyl-keyhole limpet hemocyanin (TNP-KLH), the kinetics of the response, the location and number of TNP-specific antibody-forming cells, and the different Ig classes of the antibodies produced were studied in AM-depleted animals. The results show that AM elimination has a dramatic effect on the pulmonary immune responses against TNP-KLH. An increase in APC in lung-associated lymph nodes and a prolongation of the response is found, as well as an introduction of APC in lung tissue. In both experimental groups, the majority of the TNP-specific antibodies produced was IgG, followed by IgA and IgE, while very few IgM antibodies could be detected. We conclude from these results that AM are likely to play a role in controlling the pulmonary immune response in a suppressive way, thereby limiting the possible damage caused by severe immune responses in lung tissue.
| Year | Citations | |
|---|---|---|
Page 1
Page 1